Skip to main content
SpringerLink
Log in

Komorbidität in der geriatrische Urologie

  • Chapter
  • First Online:
Die Urologie

Part of the book series: Springer Reference Medizin ((SRM))

  • 267 Accesses

Zusammenfassung

Unter Komorbidität wird das Vorliegen von mehr als einer Erkrankung bei demselben Patienten verstanden. Sie kann mit einer Vielzahl medizinischer Probleme verbunden sein. Zur Messung dieser Komorbidität wurde eine Vielzahl von Klassifikationen entwickelt, ohne dass eine davon sich allgemein durchsetzen konnte. Bisher gilt der Charlson-Score als die am häufigsten verwendete Komorbiditätsklassifikation. Neben dem Charlson-Score sind eine Vielzahl weiterer Klassifikationen verfügbar. Besondere Bedeutung hat die Beurteilung der Komorbidität bei der Abschätzung des konkurrierenden Sterberisikos in der urologischen Onkologie, vor allem beim frühen Prostatakarzinom und bei der Abschätzung des perioperativen Risikos bei größeren urologischen Operationen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 269.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J (1996) The impact of co-morbidity on life expectancy among men with localized prostate cancer. J Urol 156:127–132

    Article  CAS  PubMed  Google Scholar 

  • Alibhai SM, Leach M, Tomlinson GA, Krahn MD, Fleshner NE, Naglie G (2008) Is there an optimal comorbidity index for prostate cancer? Cancer 112(5):1043–1050. doi:10.1002/cncr.23269

    Article  PubMed  Google Scholar 

  • American Society of Anesthesiologists (2013) ASA physical status classification system. Available from: http://www.asahq.org/clinical/physicalstatus.htm. Zugegriffen am 16.12.2013

  • American Urological Association (2011) Guideline for the management of clinically localized prostate cancer: 2007 update (Reviewed and validity confirmed 2011). http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines/main-reports/proscan07/content.pdf. Zugegriffen am 23.12.2013

  • Aziz A, May M, Burger M, Palisaar RJ, Trinh QD, Fritsche HM, Rink M, Chun F, Martini T, Bolenz C, Mayr R, Pycha A, Nuhn P, Stief C, Novotny V, Wirth M, Seitz C, Noldus J, Gilfrich C, Shariat SF, Brookman-May S, Bastian PJ, Denzinger S, Gierth M, Roghmann F, PROMETRICS 2011 Research Group (2014) Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. Eur Urol 66:156 [Epub vor Druck]

    Article  PubMed  Google Scholar 

  • Barry MJ, Albertsen PC, Bagshaw MA, Blute ML, Cox R, Middleton RG, Gleason DF, Zincke H, Bergstralh EJ, Jacobsen SJ (2001) Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management: a retrospective analysis. Cancer 91:2302–2314

    Article  CAS  PubMed  Google Scholar 

  • Berger J, Fardoun T, Brassart E, Capon G, Bigot P, Bernhard JC, Rigaud J, Patard JJ, Descazeaud A (2012) Detailed analysis of morbidity following nephrectomy for renal cell carcinoma in octogenarians. J Urol 188:736–740

    Article  PubMed  Google Scholar 

  • Bianchi M, Trinh QD, Sun M, Meskawi M, Schmitges J, Shariat SF, Briganti A, Tian Z, Jeldres C, Sukumar S, Peabody JO, Graefen M, Perrotte P, Menon M, Montorsi F, Karakiewicz PI (2012) Impact of academic affiliation on radical cystectomy outcomes in North America: a population-based study. Can Urol Assoc J 6:245–250

    Article  PubMed  PubMed Central  Google Scholar 

  • Boulos DL, Groome PA, Brundage MD, Siemens DR, Mackillop WJ, Heaton JP, Schulze KM, Rohland SL (2006) Predictive validity of five comorbidity indices in prostate carcinoma patients treated with curative intent. Cancer 106:1804–1814

    Article  PubMed  Google Scholar 

  • Canadian Cardiovascular Society (2013) Canadian Cardiovascular Society grading of angina pectoris. Available from: http://www.ccs.ca/download/position_statements/Grading%20of%20Angina.pdf. Zugegriffen am 16.12.2013

  • Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383

    Article  CAS  PubMed  Google Scholar 

  • Charlson M, Szatrowski TP, Peterson J, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47:1245–1251

    Article  CAS  PubMed  Google Scholar 

  • Cruz M, Covinsky K, Widera EW, Stijacic-Cenzer I, Lee SJ (2013) Predicting 10-year mortality for older adults. JAMA 309:874–876

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Daskivich TJ, Chamie K, Kwan L, Labo J, Palvolgyi R, Dash A, Greenfield S, Litwin MS (2011) Overtreatment of men with low-risk prostate cancer and significant comorbidity. Cancer 117:2058–2066

    Article  PubMed  Google Scholar 

  • Daskivich TJ, Fan KH, Koyama T, Albertsen PC, Goodman M, Hamilton AS et al (2013) Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population–based cohort of men with prostate cancer. Ann Intern Med 158:709–717

    Article  PubMed  PubMed Central  Google Scholar 

  • Deutsche Gesellschaft für Urologie e. V. (2011) Interdisziplinäre Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms. Version 2.0 – 1. Aktualisierung 2011 [Interdisciplinary guideline of S3 quality on early detection, diagnosis and treatment of different stages of prostate cancer. Version 2.0 – 1st update 2011]. http://www.urologenportal.de/fileadmin/MDB/PDF/S3_LL_PCAS3_PCa_Aktualisierung_2011_110912f.pdf. Zugegriffen am 16.12.2013

  • Droz JP, Balducci L, Bolla M, Emberton M, Fitzpatrick JM, Joniau S, Kattan MW, Monfardini S, Moul JW, Naeim A, van Poppel H, Saad F, Sternberg CN (2010) Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology. BJU Int 106:462–469

    Article  PubMed  PubMed Central  Google Scholar 

  • Extermann M (2000) Measuring comorbidity in older cancer patients. Eur J Cancer 36:453–471

    Article  CAS  PubMed  Google Scholar 

  • Froehner M, Koch R, Litz R, Oehlschlaeger S, Noack B, Manseck A, Albrecht DM, Wirth MP (2003) Preoperative cardiopulmonary risk assessment as predictor of early non-cancer and overall mortality after radical prostatectomy. Urology 61:596–600

    Article  PubMed  Google Scholar 

  • Froehner M, Koch R, Litz RJ, Hakenberg OW, Wirth MP (2012) Which patients are at the highest risk of dying from competing causes ≤ 10 years after radical prostatectomy? BJU Int 110:206–210

    Article  PubMed  Google Scholar 

  • Froehner M, Koch R, Wirth MP (2013a) Comorbidity and mortality after brachytherapy. Int J Radiat Oncol Biol Phys 87:431

    Article  PubMed  Google Scholar 

  • Froehner M, Koch R, Wirth MP (2013b) Re: effect of age, tumor risk, and comorbidity in a U.S. Population-based cohort of men with prostate cancer. Ann Intern Med 159:370

    Article  PubMed  Google Scholar 

  • Froehner M, Hentschel C, Koch R, Litz RJ, Hakenberg OW, Wirth MP (2013c) Which comorbidity classification best fits elderly candidates for radical prostatectomy? Urol Oncol 31:461–472

    Article  PubMed  Google Scholar 

  • Froehner M, Koch R, Wirth MP (2013d) Re: American Society of Anesthesiologists (ASA) classification as predictor of survival after radical cystectomy. Eur Urol 63:e9

    Article  PubMed  Google Scholar 

  • Fröhner M (2013) Komorbiditätsindex nach Charlson. Uro-News 17:39–41

    Article  Google Scholar 

  • Goossens-Laan CA, Gooiker GA, van Gijn W, Post PN, Bosch JL, Kil PJ, Wouters MW (2011) A systematic review and meta-analysis of the relationship between hospital/surgeon volume and outcome for radical cystectomy: an update for the ongoing debate. Eur Urol 59:775–783

    Article  PubMed  Google Scholar 

  • Greenfield S, Apolone G, McNeil BJ, Cleary PD (1993) The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care 31:141–154

    Article  CAS  PubMed  Google Scholar 

  • Guzzo TJ, Dluzniewski P, Orosco R, Platz EA, Partin AW, Han M (2010) Prediction of mortality after radical prostatectomy by Charlson comorbidity index. Urology 76:553–557

    Article  PubMed  PubMed Central  Google Scholar 

  • Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, Mason MD, Matveev V, Mottet N, van der Kwast TH, Wiegel T, Zattoni F (2013) EAU guidelines on prostate cancer. Update 2013. http://www.uroweb.org/gls/pdf/09_Prostate_Cancer_LR.pdf. Zugegriffen am 16.12.2013

  • Huntley AL, Johnson R, Purdy S, Valderas JM, Salisbury C (2012) Measures of multimorbidity and morbidity burden for use in primary care and community settings: a systematic review and guide. Ann Fam Med 10:134–141

    Article  PubMed  PubMed Central  Google Scholar 

  • Junger A, Engel J, Quinzio L, Banzhaf A, Jost A, Hempelmann H (2002) Risikoindizes, Scoring-Systeme und prognostische Modelle in der Anästhesie und Intensivmedizin. Teil I: Anästhesie. Anasthesiol Intensivmed Notfallmed Schmerzther 37:520–527

    Article  CAS  PubMed  Google Scholar 

  • Kaplan MH, Feinstein AR (1974) The importance of classifying initial prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 27:387–404

    Article  CAS  PubMed  Google Scholar 

  • Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (Hrsg) Evaluation of chemotherapeutic agents. Columbia University Press, New York, S 196

    Google Scholar 

  • Kunz I, Musch M, Roggenbuck U, Klevecka V, Kroepfl D (2013) Tumour characteristics, oncological and functional outcomes in patients aged ≥ 70 years undergoing radical prostatectomy. BJU Int 111:E24–E29

    Article  PubMed  Google Scholar 

  • Kutikov A, Egleston BL, Canter D, Smaldone MC, Wong YN, Uzzo RG (2012) Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based model. J Urol 188:2077–2083

    Article  PubMed  PubMed Central  Google Scholar 

  • Lee SJ, Lindquist K, Segal MR, Covinsky KE (2006) Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 295:801–808

    Article  CAS  PubMed  Google Scholar 

  • Linn BS, Linn MW, Gurel L (1968) Cumulative illness rating scale. J Am Geriatr Soc 16:622–626

    Article  CAS  PubMed  Google Scholar 

  • Ljungberg B, Bensalah K, Bex A, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Mulders PFA, Staehler M, Volpe A (2013) Guidelines on renal cell carcinoma. Update 2013. http://www.uroweb.org/gls/pdf/10_Renal_Cell_Carcinoma_LRV2.pdf. Zugegriffen am 16.12.2013

  • Mandal S, Sankhwar SN, Kathpalia R, Singh MK, Kumar M, Goel A, Singh V, Sinha RJ, Singh BP, Dalela D (2013) Grading complications after transurethral resection of prostate using modified Clavien classification system and predicting complications using the Charlson comorbidity index. Int Urol Nephrol 45:347–354

    Article  PubMed  Google Scholar 

  • Mathieu R, Verhoest G, Droupy S, de la Taille A, Bruyere F, Doumerc N, Rischmann P, Vaessen C, Roupret M, Bensalah K (2013) Predictive factors of complications after robot-assisted laparoscopic partial nephrectomy: a retrospective multicentre study. BJU Int 112:E283–E289

    Article  PubMed  Google Scholar 

  • Mayr R, May M, Martini T, Lodde M, Comploj E, Pycha A, Strobel J, Denzinger S, Otto W, Wieland W, Burger M, Fritsche HM (2012) Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder. Eur Urol 62:662–670

    Article  PubMed  Google Scholar 

  • Morgan TM, Keegan KA, Barocas DA, Ruhotina N, Phillips SE, Chang SS, Penson DF, Clark PE, Smith JA Jr, Cookson MS (2011) Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy. J Urol 186:829–834

    Article  PubMed  Google Scholar 

  • National Comprehensive Cancer Network (2013) NCCN clinical practice guidelines in oncology (NCCN Guideline): prostate cancer, Version I. http://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf. Zugegriffen am 16.12.2013

  • National Institute for Health and Clinical Excellence (NICE) (2008) NICE clinical guideline 58: prostate cancer. Diagnosis and treatment. http://www.nice.org.uk/nicemedia/live/11924/39687/39687.pdf. Zugegriffen am 16.12.2013

  • Nepple KG, Stephenson AJ, Kallogjeri D, Michalski J, Grubb RL 3rd, Strope SA, Haslag-Minoff J, Piccirillo JF, Ciezki JP, Klein EA, Reddy CA, Yu C, Kattan MW, Kibel AS (2013) Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity. Eur Urol 64:372–378

    Article  PubMed  PubMed Central  Google Scholar 

  • Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655

    Article  CAS  PubMed  Google Scholar 

  • Quivy A, Daste A, Harbaoui A, Duc S, Bernhard JC, Gross-Goupil M, Ravaud A (2013) Optimal management of renal cell carcinoma in the elderly: a review. Clin Interv Aging 8:433–442

    PubMed  PubMed Central  Google Scholar 

  • Sand KE, Hjelle KM, Rogde AJ, Gudbrandsđottir G, Bostad L, Beisland C (2013) Incidentally detected renal cell carcinomas are highly associated with comorbidity and mortality unrelated to renal cell carcinoma. Scand J Urol 47:462–471

    Article  PubMed  Google Scholar 

  • Sandhu JS, Gotto GT, Herran LA, Scardino PT, Eastham JA, Rabbani F (2011) Age, obesity, medical comorbidities and surgical technique are predictive of symptomatic anastomotic strictures after contemporary radical prostatectomy. J Urol 185:2148–2152

    Article  PubMed  Google Scholar 

  • Sarfati D (2012) Review of methods used to measure comorbidity in cancer populations: no gold standard exists. J Clin Epidemiol 65:924–933

    Article  PubMed  Google Scholar 

  • Stier DM, Greenfield S, Lubeck DP et al (1999) Quantifying comorbidity in a disease-specific cohort: adaptation of the total illness burden index to prostate cancer. Urology 54:424–429

    Article  CAS  PubMed  Google Scholar 

  • Takada N, Abe T, Shinohara N, Sazawa A, Maruyama S, Shinno Y, Sato S, Mitsuhashi K, Sato T, Sugishita K, Kamota S, Yamashita T, Ishizaki J, Hioka T, Mouri G, Ono T, Miyajima N, Sakuta T, Mochizuki T, Aoyagi T, Katano H, Akino T, Hirakawa K, Minami K, Kumagai A, Seki T, Togashi M, Nonomura K (2012) Peri-operative morbidity and mortality related to radical cystectomy: a multi-institutional retrospective study in Japan. BJU Int 110:E756–E764

    Article  PubMed  Google Scholar 

  • Taylor JM, Feifer A, Savage CJ, Maschino AC, Bernstein M, Herr HW, Donat SM (2012) Evaluating the utility of a preoperative nomogram for predicting 90-day mortality following radical cystectomy for bladder cancer. BJU Int 109:855–859

    Article  PubMed  Google Scholar 

  • The Criteria Committee of the New York Heart Association (1994) Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9. Aufl. Little, Brown, Boston, S 253–256

    Google Scholar 

  • Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M (2009) Defining comorbidity: implications for understanding health and health services. Ann Fam Med 7:357–363

    Article  PubMed  PubMed Central  Google Scholar 

  • Verger E, Salamero M, Conill C (1992) Can Karnofsky performance stastus be transformed to the Eastern Cooperative Oncology Group scoring scale and vice-versa. Eur J Cancer 28:1328–1330

    Article  Google Scholar 

  • Walz J, Gallina A, Saad F, Montorsi F, Perrotte P, Shariat SF, Jeldres C, Graefen M, Bénard F, McCormack M, Valiquette L, Karakiewicz PI (2007) A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. J Clin Oncol 25:3576–3581

    Article  PubMed  Google Scholar 

  • Witjes JA, Compérat E, Cowan NC, De Santis M, Gakis G, Lebret T, Ribal MJ, Sherif A (2013) Guidelines on muscle-invasive and metastatic bladder cancer. Update 2013. http://www.uroweb.org/gls/pdf/07_Bladder%20Cancer_LRV2.pdf. Zugegriffen am 16.12.2013

  • Zumsteg ZS, Zelefsky MJ (2013) Improved survival with surgery in prostate cancer patients without medical comorbidity: a self-fulfilling prophecy? Eur Urol 64:381–383

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Urologie, Universitätsklinikum Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland

    Michael Fröhner

  2. Klinik und Poliklinik für Urologie, Universitätsklinikum Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland

    Manfred Wirth

Authors
  1. Michael Fröhner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manfred Wirth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Fröhner .

Editor information

Editors and Affiliations

  1. Universitätsklinikum Mannheim, Klinik für Urologie, Mannheim, Baden-Württemberg, Germany

    Maurice Stephan Michel

  2. Klinik für Urologie, Universitätsklinik Mannheim, Mainz, Germany

    Joachim W. Thüroff

  3. Abt. für Urologie, Universitätsklinikum Salzburg, Salzburg, Austria

    Günther Janetschek

  4. Klinik und Poliklinik für Urologie, Univer Tech Univ Dresden, Dresden, Germany

    Manfred Wirth

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Fröhner, M., Wirth, M. (2016). Komorbidität in der geriatrische Urologie. In: Michel, M., Thüroff, J., Janetschek, G., Wirth, M. (eds) Die Urologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-39940-4_229

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-39940-4_229

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-39939-8

  • Online ISBN: 978-3-642-39940-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation